In cases of moderate to severe LVSD, those with diabetes were more likely to be started on ACE inhibitors/ARBs (81% vs 77%, p<0.001) and β-blockers (77% vs 74%, p<0.001) than those without diabetes. The gene discussed is ACE; the disease is diabetes mellitus.